pubmed-article:19095572 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0699791 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C1704242 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0026682 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0334037 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C1519104 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:19095572 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:19095572 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19095572 | pubmed:dateCreated | 2008-12-19 | lld:pubmed |
pubmed-article:19095572 | pubmed:abstractText | Our aim was to evaluate the usefulness of the monoclonal antibody Das-1 as a premalignant marker of gastric intestinal metaplasia (GIM) associated with gastric cancer and its association with mucin expression. We evaluated Das-1 and mucin expression in 4 groups: 1 (n = 50), gastric carcinoma, paired samples of the cancer area and GIM away from the tumor; 2 (n = 25), gastric or duodenal ulcer with Helicobacter pylori infection with GIM and chronic gastritis; 3 (n = 25),H pylori- autoimmune chronic atrophic gastritis with GIM; and 4 (n = 25),H pylori- chronic gastritis without GIM. Das-1 immunostaining was observed in 20 (40%) of 50 cases in cancer areas. The expression of Das-1 in GIM from group 1 cases away from the cancer area was different from that in GIM from nontumor cases (groups 2 and 3): 13 (26%) of 50 vs 2 (8%) and 0 (0%) of 25 (P = .004). There was no association between Das-1 and mucin expression. Das-1 expression was associated with GIM from patients with gastric cancer. However, this relation was weaker than previously reported, precluding clinical usefulness as a premalignant marker of GIM. | lld:pubmed |
pubmed-article:19095572 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19095572 | pubmed:language | eng | lld:pubmed |
pubmed-article:19095572 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19095572 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19095572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19095572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19095572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19095572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19095572 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19095572 | pubmed:month | Jan | lld:pubmed |
pubmed-article:19095572 | pubmed:issn | 1943-7722 | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:SalasAntonioA | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:RosinachMercè... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:CasalotsJaume... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:Garcia-GilL... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:Fernández-Bañ... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:EsteveMariaM | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:EspinósJorgeJ | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:FornéMontserr... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:LorasCarmeC | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:González-Míng... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:Poblet-MasNúr... | lld:pubmed |
pubmed-article:19095572 | pubmed:author | pubmed-author:ViverJosep... | lld:pubmed |
pubmed-article:19095572 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19095572 | pubmed:volume | 131 | lld:pubmed |
pubmed-article:19095572 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19095572 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19095572 | pubmed:pagination | 99-105 | lld:pubmed |
pubmed-article:19095572 | pubmed:dateRevised | 2010-5-17 | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:meshHeading | pubmed-meshheading:19095572... | lld:pubmed |
pubmed-article:19095572 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19095572 | pubmed:articleTitle | Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia. | lld:pubmed |
pubmed-article:19095572 | pubmed:affiliation | Department of Gastroenterology, Hospital Universitari Mútua Terrassa, Terrassa, Spain. | lld:pubmed |
pubmed-article:19095572 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19095572 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19095572 | lld:pubmed |